AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 156 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $173 | +47.9% | 4 | 0.0% | 0.00% | – |
Q1 2024 | $117 | +30.0% | 4 | 0.0% | 0.00% | – |
Q4 2023 | $90 | -48.3% | 4 | -42.9% | 0.00% | – |
Q3 2023 | $174 | +2.4% | 7 | +16.7% | 0.00% | – |
Q2 2023 | $170 | +23.2% | 6 | 0.0% | 0.00% | – |
Q1 2023 | $138 | -38.7% | 6 | -25.0% | 0.00% | – |
Q4 2022 | $225 | – | 8 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 8 | +100.0% | 0.00% | – |
Q2 2022 | $0 | – | 4 | -33.3% | 0.00% | – |
Q1 2022 | $0 | – | 6 | +200.0% | 0.00% | – |
Q4 2021 | $0 | – | 2 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |